Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors

Clinical trial NCT00436761 · UNKNOWN

Trial details

NCT number: NCT00436761
Sponsor: Milton S. Hershey Medical Center
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Childhood Solid Tumor, Protocol Specific

Start date: 2004-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.